DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings C

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica’s website at www.diamedica.com, in the Investor Relations section. Before the […]

Related Keywords

China , Netherlands , Australia , Canada , Canadian , Australian , Dutch , Scott Kellen , Rick Pauls , Dave Wambeke , Qambar Shah , Pfizer , Technology Officer , Most Valuable It Companies , Astrazeneca , Head Of Global Vaccines Development , Glaxosmithkline , National Institute Of Health Stroke Scale , Human Genome Sciences , Chief Financial , Chief Technology , Vice President , Global Vaccines Development , Executive Director , Drug Product Development , Bristol Myers Squib , Scientific Advisory Board , Interim Chief Medical Officer , Jordan Dubow , National Institute , Health Stroke Scale , Rankin Scale , Chief Business Officer ,